Consistent with data from R5-KO mice (Figure 3d), ex vivo blockade of CCR5 in NAFLD microenvironment elevated lipogenic gene expression (Figure 6c and 6d, compare bars 1 and 2). Here, CCR5 is linked to metabolic dysfunction-associated steatotic liver disease.